Attachment 5 - Pathology Schedule of Services_09282026.xlsx

XLSX spreadsheet 170 KB Posted

Attached to
NWI Offsite Pathology Services
Solicitation number
36C26326R0063
Issued by

About this file

This is a pathology schedule of services pricing template for a federal contract opportunity with the Department of Veterans Affairs Nebraska-Western Iowa Health Care System. The document serves as an Excel-based pricing submission tool for contractors bidding on offsite pathology services (Solicitation Number 36C26326R0063).

The template requires offerors to populate laboratory information for any facilities performing tests under subcontract, identified by performing lab numbers (0-26), including laboratory name, physical address, CLIA number, and laboratory director contact information. For self-performed tests, offerors use lab number "0." The pricing schedule is organized into multiple sections covering fiscal years 2027 and 2028, with separate tabs for Profee_CMS OP1, CLIA OP1, Profee_CMS OP2, and CLIA OP2 operational periods. Each section contains hundreds of CPT/HCPCS codes spanning clinical pathology, molecular pathology, cytopathology, chemistry, hematology, coagulation, immunology, microbiology, and genetics testing. Offerors must indicate the performing laboratory for each test (by lab number), provide estimated quantities, unit pricing for contract services, CMS discount rates, and total contract pricing. The template includes an example pricing entry showing $100.00 pricing at 100% CMS rate. All pricing fields currently display $0.00, requiring contractor completion. The document emphasizes compliance with requirement DC 02.03.01 and indicates that pricing should reference CMS amounts with applicable discount rates for both send-out and in-house special pricing scenarios.

View the file

Other files

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

Summary of Lab Information Instructions to Offerors: In order to comply with DC 02.03.01, the laboratory information is required below. Populate the information for any laboratories that will be performing tests under Subcontract. On the subsequent sheets, indicate in column "E" the lab that will be utilized for the test, by the Performing Lab number. If self-performed, please utilize the number "0".

Performing LabLaboratory NameLaboratory Address (Physical Address not Business Office)Laboratory CLIA NumberLaboratory Director Name, Email and Phone number
0Contractors Lab Information hereContractors addressContractors CLIA Number(s)All POC Information
1To Be Provided by OfferorTo Be Provided by OfferorTo Be ProvidedTo Be Provided
2To Be Provided by OfferorTo Be Provided by OfferorTo Be ProvidedTo Be Provided
3To Be Provided by OfferorTo Be Provided by OfferorTo Be ProvidedTo Be Provided
4To Be Provided by OfferorTo Be Provided by OfferorTo Be ProvidedTo Be Provided
5To Be Provided by OfferorTo Be Provided by OfferorTo Be ProvidedTo Be Provided
6To Be Provided by OfferorTo Be Provided by OfferorTo Be ProvidedTo Be Provided
7To Be Provided by OfferorTo Be Provided by OfferorTo Be ProvidedTo Be Provided
8To Be Provided by OfferorTo Be Provided by OfferorTo Be ProvidedTo Be Provided
9To Be Provided by OfferorTo Be Provided by OfferorTo Be ProvidedTo Be Provided
10To Be Provided by OfferorTo Be Provided by OfferorTo Be ProvidedTo Be Provided
11To Be Provided by OfferorTo Be Provided by OfferorTo Be ProvidedTo Be Provided
12To Be Provided by OfferorTo Be Provided by OfferorTo Be ProvidedTo Be Provided
13To Be Provided by OfferorTo Be Provided by OfferorTo Be ProvidedTo Be Provided
14To Be Provided by OfferorTo Be Provided by OfferorTo Be ProvidedTo Be Provided
15To Be Provided by OfferorTo Be Provided by OfferorTo Be ProvidedTo Be Provided
16To Be Provided by OfferorTo Be Provided by OfferorTo Be ProvidedTo Be Provided
17To Be Provided by OfferorTo Be Provided by OfferorTo Be ProvidedTo Be Provided
18To Be Provided by OfferorTo Be Provided by OfferorTo Be ProvidedTo Be Provided
19To Be Provided by OfferorTo Be Provided by OfferorTo Be ProvidedTo Be Provided
20To Be Provided by OfferorTo Be Provided by OfferorTo Be ProvidedTo Be Provided
21To Be Provided by OfferorTo Be Provided by OfferorTo Be ProvidedTo Be Provided
22To Be Provided by OfferorTo Be Provided by OfferorTo Be ProvidedTo Be Provided
23To Be Provided by OfferorTo Be Provided by OfferorTo Be ProvidedTo Be Provided
24To Be Provided by OfferorTo Be Provided by OfferorTo Be ProvidedTo Be Provided
25To Be Provided by OfferorTo Be Provided by OfferorTo Be ProvidedTo Be Provided
26To Be Provided by OfferorTo Be Provided by OfferorTo Be ProvidedTo Be Provided

Profee_CMS OP1

Laboratory Performing Test (Populate corresponding number from Summary of Lab Information, For Self-performed tests, utilize the number '0')Estimated QuantityUNIT PRICING FOR CONTRACTCMS Discount Rate (Enter Discount of CMS Amount)TOTAL CONTRACT PRICING
*KEY
100% of CMS Pricing
*Send Outs
**In-House Special Pricing
SLINYearHCPCS / CPTSend OutsMODDESCRIPTION
202712345Example: Random Test1$100.00100.00%$100.00
0001AA202781403Mopath procedure level 424$0.00
0001AB202781479Unlisted molecular pathology28$0.00
0001AC202782010Ketone bodys quan4$0.00
0001AD202784220Assay of pyruvate kinase12$0.00
0001AE202785060Blood smear interpretation5$0.00
0001AF202785097Bone marrow interpretation32$0.00
0001AG202786849Immunology procedure2$0.00
0001AH202788040Forensic autopsy - Full (necropsy)0$0.00
0001AJ202788099Unlisted necropsy (autopsy)0$0.00
0001AK202788104Cytopath fl nongyn smears29$0.00
0001AL202788104TCCytopath fl nongyn smears0$0.00
0001AM20278810426Cytopath fl nongyn smears0$0.00
0001AN202788106Cytopath fl nongyn filter3$0.00
0001AP202788106TCCytopath fl nongyn filter0$0.00
0001AQ202788108Cytopath concentrate tech8$0.00
0001AR202788108TCCytopath concentrate tech0$0.00
0001AS202788112Cytopath cell enhance tech576$0.00
0001AT202788112TCCytopath cell enhance tech0$0.00
0001AU202788120Cytp urne 3-5 probes ea spec8$0.00
0001AV202788120TCCytp urne 3-5 probes ea spec0$0.00
0001AW202788121Cytp urine 3-5 probes cmptr8$0.00
0001AX202788121TCCytp urine 3-5 probes cmptr0$0.00
0001AY202788141Cytopath c/v interpret13$0.00
0001AZ202788160Cytopath smear other source10$0.00
0001BA202788160TCCytopath smear other source0$0.00
0001BB20278816026Cytopath smear other source0$0.00
0001BC202788161Cytopath smear other source6$0.00
0001BD202788161TCCytopath smear other source0$0.00
0001BE20278816126Cytopath smear other source0$0.00
0001BF202788162Cytopath smear other source6$0.00
0001BG202788162TCCytopath smear other source0$0.00
0001BH20278816226Cytopath smear other source0$0.00
0001BJ202788172Cytp dx eval fna 1st ea site6$0.00
0001BK202788172TCCytp dx eval fna 1st ea site0$0.00
0001BL202788173Cytopath eval fna report49$0.00
0001BM202788173TCCytopath eval fna report0$0.00
0001BN202788177Cytp fna eval ea addl9$0.00
0001BP202788177TCCytp fna eval ea addl0$0.00
0001BQ20278817726Cytp fna eval ea addl0$0.00
0001BR202788182Cell marker study2$0.00
0001BS202788182TCCell marker study0$0.00
0001BT202788184Flowcytometry/ tc 1 marker184$0.00
0001BU202788185Flowcytometry/tc add-on31$0.00
0001BV202788187Flowcytometry/read 2-833$0.00
0001BW202788188Flowcytometry/read 9-1535$0.00
0001BX202788189Flowcytometry/read 16 & >60$0.00
0001BY202788027Necropsy (Autopsy), gross & microscopic with Brain and Spinal Cord4$0.00
0001BZ202788047Autopsy - Electrolyte Panel0$0.00
0001CA202780307Autopsy - Comprehensive Drug Panel, Blood0
0001CB202788291Cyto/molecular report1$0.00
0001CC202788300Surgical path gross0$0.00
0001CD202788300TCSurgical path gross156$0.00
0001CE202788302Tissue exam by pathologist0$0.00
0001CF202788302TCTissue exam by pathologist47$0.00
0001CG20278830226Tissue exam by pathologist0$0.00
0001CH202788304Tissue exam by pathologist0$0.00
0001CJ202788304TCTissue exam by pathologist266$0.00
0001CK20278830426Tissue exam by pathologist0$0.00
0001CL202788305Tissue exam by pathologist0$0.00
0001CM202788305TCTissue exam by pathologist1075$0.00
0001CN20278830526Tissue exam by pathologist0$0.00
0001CP202788307Tissue exam by pathologist0$0.00
0001CQ202788307TCTissue exam by pathologist494$0.00
0001CR20278830726Tissue exam by pathologist0$0.00
0001CS202788309Tissue exam by pathologist0$0.00
0001CT202788309TCTissue exam by pathologist141$0.00
0001CU20278830926Tissue exam by pathologist0$0.00
0001CV202788311Decalcify tissue0$0.00
0001CW202788311TCDecalcify tissue58$0.00
0001CX202788312Special stains group 10$0.00
0001CY202788312TCSpecial stains group 1308$0.00
0001CZ202788313Special stains group 20$0.00
0001DA202788313TCSpecial stains group 2222$0.00
0001DB20278831326Special stains group 20$0.00
0001DC202788314Histochemical stains add-on13$0.00
0001DD202788314TCHistochemical stains add-on24$0.00
0001DE202788319Enzyme histochemistry9$0.00
0001DF202788319TCEnzyme histochemistry5$0.00
0001DG202788321Consltj&reprt sld prep elswr56$0.00
0001DH202788323Consltj&reprt matrl prep sld29$0.00
0001DJ202788341Imhchem/imcytchm ea add antb0$0.00
0001DK202788341TCImhchem/imcytchm ea add antb266$0.00
0001DL20278834126Imhchem/imcytchm ea add antb0$0.00
0001DM202788342Imhchem/imcytchm 1st antb0$0.00
0001DN202788342TCImhchem/imcytchm 1st antb202$0.00
0001DP20278834226Imhchem/imcytchm 1st antb0$0.00
0001DQ202788344Imhchem/imcytchm ea mlt antb0$0.00
0001DR202788344TCImhchem/imcytchm ea mlt antb119$0.00
0001DS202788346Imfluor 1st 1antb stain px0$0.00
0001DT202788346TCImfluor 1st 1antb stain px79$0.00
0001DU202788348Electron microscopy dx12$0.00
0001DV202788348TCElectron microscopy dx9$0.00
0001DW202788350Imfluor ea addl 1antb stn px55$0.00
0001DX202788350TCImfluor ea addl 1antb stn px21$0.00
0001DY202788360Tumor immunohistochem/manual24$0.00
0001DZ202788360TCTumor immunohistochem/manual32$0.00
0001EA202788361TCTumor immunohistochem/comput1$0.00
0001EB202788364Insitu hybridization (fish)17$0.00
0001EC202788364TCInsitu hybridization (fish)23$0.00
0001ED202788365Insitu hybridization (fish)29$0.00
0001EE202788365TCInsitu hybridization (fish)32$0.00
0001EF202788367TCInsitu hybridization auto1$0.00
0001EG202788368TCInsitu hybridization manual9$0.00
0001EH202788374M/phmtrc alys ishquant/semiq28$0.00
0001EJ202788377M/phmtrc alys ishquant/semiq34$0.00
0001EK202788377TCM/phmtrc alys ishquant/semiq7$0.00
0001EL202788381Microdissection manual16$0.00
0001EM202788381TCMicrodissection manual9$0.00
0001EN202788399Unlisted surgical path px3$0.00
0001EP202789240Unlisted misc path test33$0.00
0001EQ202799001Specimen handling pt-lab2$0.00
0001ER2027TBDMiscellaneous test varies depending on methodology/pathways0TBDERROR:#VALUE!
$0.00

$0.00

CLIA OP1

*KEY
100% of CMS Pricing
*Send Outs
**In-House Special Pricing
SLINYEARHCSPCS / CPTSend OutsMODShort DescriptionExtended DescriptionLaboratory Performing Test (Populate corresponding number from Summary of Lab Information, For Self-performed tests, utilize the number '0')CMS INDICATOREstimated QuantityUNIT PRICING FOR CONTRACTCMS Discount Rate (Enter Discount of CMS Amount)TOTAL - CONTRACT PRICING
202712345Example: Random Test5$100.00100.00%$500.00100.00%
0002AA20270012MOnc mrna 5 gen rsk urthl caOncology (urothelial), mrna, gene expression profiling by real-time quantitative pcr of five genes (mdk, hoxa13, cdc2 [cdk1], igfbp5, and cxcr2), utilizing urine, algorithm reported as a risk score for having urothelial carcinomaN1$0.00
0002AB20270013MOnc mrna 5 gen recr urthl caOncology (urothelial), mrna, gene expression profiling by real-time quantitative pcr of five genes (mdk, hoxa13, cdc2 [cdk1], igfbp5, and cxcr2), utilizing urine, algorithm reported as a risk score for having recurrent urothelial carcinomaN1$0.00
0002AC20270035UNeuro csf prion prtn qualNeurology (prion disease), cerebrospinal fluid, detection of prion protein by quaking-induced conformational conversion, qualitativeN1$0.00
0002AD202780047Metabolic panel ionized caBasic metabolic panel (calcium, ionized) this panel must include the following: calcium, ionized (82330) carbon dioxide (bicarbonate) (82374) chloride (82435) creatinine (82565) glucose (82947) potassium (84132) sodium (84295) urea nitrogen (bun) (84520)N1$0.00
0002AE202780048Metabolic panel total caBasic metabolic panel (calcium, total) this panel must include the following: calcium, total (82310) carbon dioxide (bicarbonate) (82374) chloride (82435) creatinine (82565) glucose (82947) potassium (84132) sodium (84295) urea nitrogen (bun) (84520)N4$0.00
0002AF202780053Comprehen metabolic panelComprehensive metabolic panel this panel must include the following: albumin (82040) bilirubin, total (82247) calcium, total (82310) carbon dioxide (bicarbonate) (82374) chloride (82435) creatinine (82565) glucose (82947) phosphatase, alkaline (84075) potassium (84132) protein, total (84155) sodium (84295) transferase, alanine amino (alt) (sgpt) (84460) transferase, aspartate amino (ast) (sgot) (84450) urea nitrogen (bun) (84520)N13$0.00
0002AG202780061Lipid panelLipid panel this panel must include the following: cholesterol, serum, total (82465) lipoprotein, direct measurement, high density cholesterol (hdl cholesterol) (83718) triglycerides (84478)N1$0.00
0002AH202780150Assay of amikacinAmikacinN1$0.00
0002AJ202780156Assay carbamazepine totalCarbamazepine; totalN1$0.00
0002AK202780170Assay of gentamicinGentamicinN1$0.00
0002AL202780185Assay of phenytoin totalPhenytoin; totalN1$0.00
0002AM202780186Assay of phenytoin freePhenytoin; freeN1$0.00
0002AN202780194Assay of quinidineQuinidineN1$0.00
0002AP202780197Assay of tacrolimusTacrolimusN1$0.00
0002AQ202780202Assay of vancomycinVancomycinN5$0.00
0002AR202780204Drug assay methotrexateMethotrexateN3$0.00
0002AS202780299Quantitative assay drugQuantitation of therapeutic drug, not elsewhere specifiedN73$0.00
0002AT202780305Drug test prsmv dir opt obsDrug test(s), presumptive, any number of drug classes, any number of devices or procedures; capable of being read by direct optical observation only (eg, utilizing immunoassay [eg, dipsticks, cups, cards, or cartridges]), includes sample validation when performed, per date of serviceN1$0.00
0002AU202780306Drug test prsmv instrmntDrug test(s), presumptive, any number of drug classes, any number of devices or procedures; read by instrument assisted direct optical observation (eg, utilizing immunoassay [eg, dipsticks, cups, cards, or cartridges]), includes sample validation when performed, per date of serviceN1$0.00
0002AV202780307Drug test prsmv chem anlyzrDrug test(s), presumptive, any number of drug classes, any number of devices or procedures; by instrument chemistry analyzers (eg, utilizing immunoassay [eg, eia, elisa, emit, fpia, ia, kims, ria]), chromatography (eg, gc, hplc), and mass spectrometry either with or without chromatography, (eg, dart, desi, gc-ms, gc-ms/ms, lc-ms, lc-ms/ms, ldtd, maldi, tof) includes sample validation when performed, per date of serviceN2$0.00
0002AW202781120Idh1 common variantsIdh1 (isocitrate dehydrogenase 1 [nadp+], soluble) (eg, glioma), common variants (eg, r132h, r132c)N16$0.00
0002AX202781121Idh2 common variantsIdh2 (isocitrate dehydrogenase 2 [nadp+], mitochondrial) (eg, glioma), common variants (eg, r140w, r172m)N15$0.00
0002AY202781170Abl1 geneAbl1 (abl proto-oncogene 1, non-receptor tyrosine kinase) (eg, acquired imatinib tyrosine kinase inhibitor resistance), gene analysis, variants in the kinase domainN5$0.00
0002AZ202781206Bcr/abl1 gene major bpBcr/abl1 (t(9;22)) (eg, chronic myelogenous leukemia) translocation analysis; major breakpoint, qualitative or quantitativeN40$0.00
0002BA202781207Bcr/abl1 gene minor bpBcr/abl1 (t(9;22)) (eg, chronic myelogenous leukemia) translocation analysis; minor breakpoint, qualitative or quantitativeN9$0.00
0002BB202781210Braf geneBraf (b-raf proto-oncogene, serine/threonine kinase) (eg, colon cancer, melanoma), gene analysis, v600 variant(s)N5$0.00
0002BC202781219Calr gene com variantsCalr (calreticulin) (eg, myeloproliferative disorders), gene analysis, common variants in exon 9N11$0.00
0002BD202781245Flt3 geneFlt3 (fms-related tyrosine kinase 3) (eg, acute myeloid leukemia), gene analysis; internal tandem duplication (itd) variants (ie, exons 14, 15)N68$0.00
0002BE202781246Flt3 gene analysisFlt3 (fms-related tyrosine kinase 3) (eg, acute myeloid leukemia), gene analysis; tyrosine kinase domain (tkd) variants (eg, d835, i836)N7$0.00
0002BF202781261Igh gene rearrange amp methIgh@ (immunoglobulin heavy chain locus) (eg, leukemias and lymphomas, b-cell), gene rearrangement analysis to detect abnormal clonal population(s); amplified methodology (eg, polymerase chain reaction)N12$0.00
0002BG202781270Jak2 geneJak2 (janus kinase 2) (eg, myeloproliferative disorder) gene analysis, p.val617phe (v617f) variantN244$0.00
0002BH202781272Kit gene targeted seq analysKit (v-kit hardy-zuckerman 4 feline sarcoma viral oncogene homolog) (eg, gastrointestinal stromal tumor [gist], acute myeloid leukemia, melanoma), gene analysis, targeted sequence analysis (eg, exons 8, 11, 13, 17, 18)N8$0.00
0002BJ202781275Kras gene variants exon 2Kras (kirsten rat sarcoma viral oncogene homolog) (eg, carcinoma) gene analysis; variants in exon 2 (eg, codons 12 and 13)N22$0.00
0002BK202781276Kras gene addl variantsKras (kirsten rat sarcoma viral oncogene homolog) (eg, carcinoma) gene analysis; additional variant(s) (eg, codon 61, codon 146)N5$0.00
0002BL202781301Microsatellite instabilityMicrosatellite instability analysis (eg, hereditary non-polyposis colorectal cancer, lynch syndrome) of markers for mismatch repair deficiency (eg, bat25, bat26), includes comparison of neoplastic and normal tissue, if performedN5$0.00
0002BM202781305Myd88 gene p.leu265pro vrntMyd88 (myeloid differentiation primary response 88) (eg, waldenstrom's macroglobulinemia, lymphoplasmacytic leukemia) gene analysis, p.leu265pro (l265p) variantN10$0.00
0002BN202781310Npm1 geneNpm1 (nucleophosmin) (eg, acute myeloid leukemia) gene analysis, exon 12 variantsN40$0.00
0002BP202781311Nras gene variants exon 2&3Nras (neuroblastoma ras viral [v-ras] oncogene homolog) (eg, colorectal carcinoma), gene analysis, variants in exon 2 (eg, codons 12 and 13) and exon 3 (eg, codon 61)N5$0.00
0002BQ202781314Pdgfra geneN12$0.00
0002BR202781315Pml/raralpha com breakpointsPml/raralpha, (t(15;17)), (promyelocytic leukemia/retinoic acid receptor alpha) (eg, promyelocytic leukemia) translocation analysis; common breakpoints (eg, intron 3 and intron 6), qualitative or quantitativeN4$0.00
0002BS202781342Trg gene rearrangement analTrg@ (t cell antigen receptor, gamma) (eg, leukemia and lymphoma), gene rearrangement analysis, evaluation to detect abnormal clonal population(s)N76$0.00
0002BT202781345Tert gene targeted seq alysTert (telomerase reverse transcriptase) (eg, thyroid carcinoma, glioblastoma multiforme) gene analysis, targeted sequence analysis (eg, promoter region)N1$0.00
0002BU202781401Mopath procedure level 2Molecular pathology procedure, level 2 (eg, 2-10 snps, 1 methylated variant, or 1 somatic variant [typically using nonsequencing target variant analysis], or detection of a dynamic mutation disorder/triplet repeat) abcc8 (atp-binding cassette, sub-family c [cftr/mrp], member 8) (eg, familial hyperinsulinism), common variants (eg, c.3898-9g>a [c.3992-9g>a], f1388del) abl1 (abl proto-oncogene 1, non-receptor tyrosine kinase) (eg, acquired imatinib resistance), t315i variant acadm (acyl-coa dehydrogenase, c-4 to c-12 straight chain, mcad) (eg, medium chain acyl dehydrogenase deficiency), commons variants (eg, k304e, y42h) adrb2 (adrenergic beta-2 receptor surface) (eg, drug metabolism), common variants (eg, g16r, q27e) apob (apolipoprotein b) (eg, familial hypercholesterolemia type b), common variants (eg, r3500q, r3500w) apoe (apolipoprotein e) (eg, hyperlipoproteinemia type iii, cardiovascular disease, alzheimer disease), common variants (eg, *2, *3, *4) cbfb/myh11 (inv(16)) (eg, acute myeloid leukemia), qualitative, and quantitative, if performed cbs (cystathionine-beta-synthase) (eg, homocystinuria, cystathionine beta-synthase deficiency), common variants (eg, i278t, g307s) cfh/arms2 (complement factor h/age-related maculopathy susceptibility 2) (eg, macular degeneration), common variants (eg, y402h [cfh], a69s [arms2]) dek/nup214 (t(6;9)) (eg, acute myeloid leukemia), translocation analysis, qualitative, and quantitative, if performed e2a/pbx1 (t(1;19)) (eg, acute lymphocytic leukemia), translocation analysis, qualitative, and quantitative, if performed eml4/alk (inv(2)) (eg, non-small cell lung cancer), translocation or inversion analysis etv6/runx1 (t(12;21)) (eg, acute lymphocytic leukemia), translocation analysis, qualitative, and quantitative, if performed ewsr1/atf1 (t(12;22)) (eg, clear cell sarcoma), translocation analysis, qualitative, and quantitative, if performed ewsr1/erg (t(21;22)) (eg, ewing sarcoma/peripheral neuroectodermal tumor), translocation analysis, qualitative, and quantitative, if performed ewsr1/fli1 (t(11;22)) (eg, ewing sarcoma/peripheral neuroectodermal tumor), translocation analysis, qualitative, and quantitative, if performed ewsr1/wt1 (t(11;22)) (eg, desmoplastic small round cell tumor), translocation analysis, qualitative, and quantitative, if performed f11 (coagulation factor xi) (eg, coagulation disorder), common variants (eg, e117x [type ii], f283l [type iii], ivs14del14, and ivs14+1g>a [type i]) fgfr3 (fibroblast growth factor receptor 3) (eg, achondroplasia, hypochondroplasia), common variants (eg, 1138g>a, 1138g>c, 1620c>a, 1620c>g) fip1l1/pdgfra (del[4q12]) (eg, imatinib-sensitive chronic eosinophilic leukemia), qualitative, and quantitative, if performed flg (filaggrin) (eg, ichthyosis vulgaris), common variants (eg, r501x, 2282del4, r2447x, s3247x, 3702delg) foxo1/pax3 (t(2;13)) (eg, alveolar rhabdomyosarcoma), translocation analysis, qualitative, and quantitative, if performed foxo1/pax7 (t(1;13)) (eg, alveolar rhabdomyosarcoma), translocation analysis, qualitative, and quantitative, if performed fus/ddit3 (t(12;16)) (eg, myxoid liposarcoma), translocation analysis, qualitative, and quantitative, if performed galc (galactosylceramidase) (eg, krabbe disease), common variants (eg, c.857g>a, 30-kb deletion) galt (galactose-1-phosphate uridylyltransferase) (eg, galactosemia), common variants (eg, q188r, s135l, k285n, t138m, l195p, y209c, ivs2-2a>g, p171s, del5kb, n314d, l218l/n314d) h19 (imprinted maternally expressed transcript [non-protein coding]) (eg, beckwith-wiedemann syndrome), methylation analysis igh@/bcl2 (t(14;18)) (eg, follicular lymphoma), translocation analysis; single breakpoint (eg, major breakpoint region [mbr] or minor cluster region [mcr]), qualitative or quantitative (when both mbr and mcr breakpoints are performed, use 81278) kcnq1ot1 (kcnq1 overlapping transcript 1 [non-protein coding]) (eg, beckwith-wiedemann syndrome), methylation analysis linc00518 (long intergenic non-protein coding rna 518) (eg, melanoma), expression analysis lrrk2 (leucine-rich repeat kinase 2) (eg, parkinson disease), common variants (eg, r1441g, g2019s, i2020t) med12 (mediator complex subunit 12) (eg, fg syndrome type 1, lujan syndrome), common variants (eg, r961w, n1007s) meg3/dlk1 (maternally expressed 3 [non-protein coding]/delta-like 1 homolog [drosophila]) (eg, intrauterine growth retardation), methylation analysis mll/aff1 (t(4;11)) (eg, acute lymphoblastic leukemia), translocation analysis, qualitative, and quantitative, if performed mll/mllt3 (t(9;11)) (eg, acute myeloid leukemia), translocation analysis, qualitative, and quantitative, if performed mt-atp6 (mitochondrially encoded atp synthase 6) (eg, neuropathy with ataxia and retinitis pigmentosa [narp], coli]) (eg, myh-associated polyposis), common variants (eg, y165c, g382d) nod2 (nucleotide-binding oligomerization domain containing 2) (eg, crohn's disease, blau syndrome), common variants (eg, snp 8, snp 12, snp 13) npm1/alk (t(2;5)) (eg, anaplastic large cell lymphoma), translocation analysis pax8/pparg (t(2;3) (q13;p25)) (eg, follicular thyroid carcinoma), translocation analysis prame (preferentially expressed antigen in melanoma) (eg, melanoma), expression analysis prss1 (protease, serine, 1 [trypsin 1]) (eg, hereditary pancreatitis), common variants (eg, n29i, a16v, r122h) pygm (phosphorylase, glycogen, muscle) (eg, glycogen storage disease type v, mcardle disease), common variants (eg, r50x, g205s) runx1/runx1t1 (t(8;21)) (eg, acute myeloid leukemia) translocation analysis, qualitative, and quantitative, if performed ss18/ssx1 (t(x;18)) (eg, synovial sarcoma), translocation analysis, qualitative, and quantitative, if performed ss18/ssx2 (t(x;18)) (eg, synovial sarcoma), translocation analysis, qualitative, and quantitative, if performed vwf (von willebrand factor) (eg, von willebrand disease type 2n), common variants (eg, t791m, r816w, r854q)N7$0.00
0002BV202781403Mopath procedure level 4Molecular pathology procedure, level 4 (eg, analysis of single exon by dna sequence analysis, analysis of >10 amplicons using multiplex pcr in 2 or more independent reactions, mutation scanning or duplication/deletion variants of 2-5 exons) ang (angiogenin, ribonuclease, rnase a family, 5) (eg, amyotrophic lateral sclerosis), full gene sequence arx (aristaless related homeobox) (eg, x-linked lissencephaly with ambiguous genitalia, x-linked intellectual disability), duplication/deletion analysis cel (carboxyl ester lipase [bile salt-stimulated lipase]) (eg, maturity-onset diabetes of the young [mody]), targeted sequence analysis of exon 11 (eg, c.1785delc, c.1686delt) ctnnb1 (catenin [cadherin-associated protein], beta 1, 88kda) (eg, desmoid tumors), targeted sequence analysis (eg, exon 3) daz/sry (deleted in azoospermia and sex determining region y) (eg, male infertility), common deletions (eg, azfa, azfb, azfc, azfd) dnmt3a (dna [cytosine-5-]-methyltransferase 3 alpha) (eg, acute myeloid leukemia), targeted sequence analysis (eg, exon 23) epcam (epithelial cell adhesion molecule) (eg, lynch syndrome), duplication/deletion analysis f8 (coagulation factor viii) (eg, hemophilia a), inversion analysis, intron 1 and intron 22a f12 (coagulation factor xii [hageman factor]) (eg, angioedema, hereditary, type iii; factor xii deficiency), targeted sequence analysis of exon 9 fgfr3 (fibroblast growth factor receptor 3) (eg, isolated craniosynostosis), targeted sequence analysis (eg, exon 7) (for targeted sequence analysis of multiple fgfr3 exons, use 81404) gjb1 (gap junction protein, beta 1) (eg, charcot-marie-tooth x-linked), full gene sequence gnaq (guanine nucleotide-binding protein g[q] subunit alpha) (eg, uveal melanoma), common variants (eg, r183, q209) human erythrocyte antigen gene analyses (eg, slc14a1 [kidd blood group], bcam [lutheran blood group], icam4 [landsteiner-wiener blood group], slc4a1 [diego blood group], aqp1 [colton blood group], ermap [scianna blood group], rhce [rh blood group, ccee antigens], kel [kell blood group], darc [duffy blood group], gypa, gypb, gype [mns blood group], art4 [dombrock blood group]) (eg, sickle-cell disease, thalassemia, hemolytic transfusion reactions, hemolytic disease of the fetus or newborn), common variants hras (v-ha-ras harvey rat sarcoma viral oncogene homolog) (eg, costello syndrome), exon 2 sequence kcnc3 (potassium voltage-gated channel, shaw-related subfamily, member 3) (eg, spinocerebellar ataxia), targeted sequence analysis (eg, exon 2) kcnj2 (potassium inwardly-rectifying channel, subfamily j, member 2) (eg, andersen-tawil syndrome), full gene sequence kcnj11 (potassium inwardly-rectifying channel, subfamily j, member 11) (eg, familial hyperinsulinism), full gene sequence killer cell immunoglobulin-like receptor (kir) gene family (eg, hematopoietic stem cell transplantation), genotyping of kir family genes known familial variant not otherwise specified, for gene listed in tier 1 or tier 2, or identified during a genomic sequencing procedure, dna sequence analysis, each variant exon (for a known familial variant that is considered a common variant, use specific common variant tier 1 or tier 2 code) mc4r (melanocortin 4 receptor) (eg, obesity), full gene sequence mica (mhc class i polypeptide-related sequence a) (eg, solid organ transplantation), common variants (eg, *001, *002) mt-rnr1 (mitochondrially encoded 12s rna) (eg, nonsyndromic hearing loss), full gene sequence mt-ts1 (mitochondrially encoded trna serine 1) (eg, nonsyndromic hearing loss), full gene sequence ndp (norrie disease [pseudoglioma]) (eg, norrie disease), duplication/deletion analysis nhlrc1 (nhl repeat containing 1) (eg, progressive myoclonus epilepsy), full gene sequence phox2b (paired-like homeobox 2b) (eg, congenital central hypoventilation syndrome), duplication/deletion analysis pln (phospholamban) (eg, dilated cardiomyopathy, hypertrophic cardiomyopathy), full gene sequence rhd (rh blood group, d antigen) (eg, hemolytic disease of the fetus and newborn, rh maternal/fetal compatibility), deletion analysis (eg, exons 4, 5, and 7, pseudogene) rhd (rh blood group, d antigen) (eg, hemolytic disease of the fetus and newborn, rh maternal/fetal compatibility), deletion analysis (eg, exons 4, 5, and 7, pseudogene), performed on cell-free fetal dna in maternal blood (for human erythrocyte gene analysis of rhd, use a separate unit of 81403) sh2d1a (sh2 domain containing 1a) (eg, x-linked lymphoproliferative syndrome), duplication/deletion analysis twist1 (twist homolog 1 [drosophila]) (eg, saethre-chotzen syndrome), duplication/deletion analysis uba1 (ubiquitin-like modifier activating enzyme 1) (eg, spinal muscular atrophy, x-linked), targeted sequence analysis (eg, exon 15) vhl (von hippel-lindau tumor suppressor) (eg, von hippel-lindau familial cancer syndrome), deletion/duplication analysis vwf (von willebrand factor) (eg, von willebrand disease types 2a, 2b, 2m), targeted sequence analysis (eg, exon 28)N104$0.00
0002BW202781425Genome sequence analysisGenome (eg, unexplained constitutional or heritable disorder or syndrome); sequence analysisN1$0.00
0002BX202781445So neo gsap 5-50dna/dna&rnaSolid organ neoplasm, genomic sequence analysis panel, 5-50 genes, interrogation for sequence variants and copy number variants or rearrangements, if performed; dna analysis or combined dna and rna analysisN9$0.00
0002BY202781450Hl neo gsap 5-50dna/dna&rnaHematolymphoid neoplasm or disorder, genomic sequence analysis panel, 5-50 genes, interrogation for sequence variants, and copy number variants or rearrangements, or isoform expression or mrna expression levels, if performed; dna analysis or combined dna and rna analysisN5$0.00
0002BZ202781546Onc thyr mrna 10,196 gen algOncology (thyroid), mrna, gene expression analysis of 10,196 genes, utilizing fine needle aspirate, algorithm reported as a categorical result (eg, benign or suspicious)N12$0.00
0002CA202782010Ketone bodys quanKetone body(s) (eg, acetone, acetoacetic acid, beta-hydroxybutyrate); quantitativeN7$0.00
0002CB202782043Ur albumin quantitativeAlbumin; urine (eg, microalbumin), quantitativeN8$0.00
0002CC202782105Alpha-fetoprotein serumAlpha-fetoprotein (afp); serumN4$0.00
0002CD202782172Assay of apolipoproteinApolipoprotein, eachN1$0.00
0002CE202782175Assay of arsenicArsenicN1$0.00
0002CF202782261Assay of biotinidaseBiotinidase, each specimenN25$0.00
0002CG202782271Occult blood other sourcesBlood, occult, by peroxidase activity (eg, guaiac), qualitative; other sourcesN16$0.00
0002CH202782330Assay of calciumCalcium; ionizedN5$0.00
0002CJ202782365Calculus spectroscopyCalculus; infrared spectroscopyN432$0.00
0002CK202782533Total cortisolCortisol; totalN1$0.00
0002CL202782542Col chromotography qual/quanColumn chromatography, includes mass spectrometry, if performed (eg, hplc, lc, lc/ms, lc/ms-ms, gc, gc/ms-ms, gc/ms, hplc/ms), non-drug analyte(s) not elsewhere specified, qualitative or quantitative, each specimenN60$0.00
0002CM202782550Assay of ck (cpk)Creatine kinase (ck), (cpk); totalN1$0.00
0002CN202782552Assay of cpk in bloodCreatine kinase (ck), (cpk); isoenzymesN1$0.00
0002CP202782553Creatine mb fractionCreatine kinase (ck), (cpk); mb fraction onlyN1$0.00
0002CQ202782565Assay of creatinineCreatinine; bloodN20$0.00
0002CR202782585Assay of cryofibrinogenCryofibrinogenN9$0.00
0002CS202782595Assay of cryoglobulinCryoglobulin, qualitative or semi-quantitative (eg, cryocrit)N7$0.00
0002CT202782607Vitamin b-12Cyanocobalamin (vitamin b-12);N4$0.00
0002CU202782693Assay of ethylene glycolEthylene glycolN5$0.00
0002CV202782705Fats/lipids feces qualFat or lipids, feces; qualitativeN21$0.00
0002CW202782728Assay of ferritinFerritinN3$0.00
0002CX202782746Assay of folic acid serumFolic acid; serumN5$0.00
0002CY202782784Assay iga/igd/igg/igm eachGammaglobulin (immunoglobulin); iga, igd, igg, igm, eachN1$0.00
0002CZ202782787Igg 1 2 3 or 4 eachGammaglobulin (immunoglobulin); immunoglobulin subclasses (eg, igg1, 2, 3, or 4), eachN12$0.00
0002DA202782945Glucose other fluidGlucose, body fluid, other than bloodN1$0.00
0002DB202783001Assay of gonadotropin (fsh)Gonadotropin; follicle stimulating hormone (fsh)N1$0.00
0002DC202783021Hemoglobin chromotographyHemoglobin fractionation and quantitation; chromatography (eg, a2, s, c, and/or f)N1$0.00
0002DD202783036Hemoglobin glycosylated a1cHemoglobin; glycosylated (a1c)N32$0.00
0002DE202783050Hgb methemoglobin quanHemoglobin; methemoglobin, quantitativeN16$0.00
0002DF202783516Immunoassay nonantibodyImmunoassay for analyte other than infectious agent antibody or infectious agent antigen; qualitative or semiquantitative, multiple step methodN1$0.00
0002DG202783520Immunoassay quant nos nonabImmunoassay for analyte other than infectious agent antibody or infectious agent antigen; quantitative, not otherwise specifiedN1$0.00
0002DH202783540Assay of ironIronN1$0.00
0002DJ202783735Assay of magnesiumMagnesiumN20$0.00
0002DK202783930Assay of blood osmolalityOsmolality; bloodN4$0.00
0002DL202783935Assay of urine osmolalityOsmolality; urineN5$0.00
0002DM202783970Assay of parathormoneParathormone (parathyroid hormone)N5$0.00
0002DN202783986Assay ph body fluid nosPh; body fluid, not otherwise specifiedN7$0.00
0002DP202784120Assay of urine porphyrinsPorphyrins, urine; quantitation and fractionationN4$0.00
0002DQ202784132Assay of serum potassiumPotassium; serum, plasma or whole bloodN5$0.00
0002DR202784145Procalcitonin (pct)Procalcitonin (pct)N3$0.00
0002DS202784153Assay of psa totalProstate specific antigen (psa); totalN1$0.00
0002DT202784160Assay of protein any sourceProtein, total, by refractometry, any sourceN5$0.00
0002DU202784220Assay of pyruvate kinasePyruvate kinaseN25$0.00
0002DV202784302Assay of sweat sodiumSodium; other sourceN13$0.00
0002DW202784377Sugars multiple qualSugars (mono-, di-, and oligosaccharides); multiple qualitative, each specimenN1$0.00
0002DX202784403Assay of total testosteroneTestosterone; totalN5$0.00
0002DY202784439Assay of free thyroxineThyroxine; freeN3$0.00
0002DZ202784443Assay thyroid stim hormoneThyroid stimulating hormone (tsh)N5$0.00
0002EA202784478Assay of triglyceridesTriglyceridesN1$0.00
0002EB202784481Free assay (ft-3)Triiodothyronine t3; freeN3$0.00
0002EC202784484Assay of troponin quantTroponin, quantitativeN2$0.00
0002ED202784520Assay of urea nitrogenUrea nitrogen; quantitativeN12$0.00
0002EE202784600Assay of volatilesVolatiles (eg, acetic anhydride, diethylether)N5$0.00
0002EF202784703Chorionic gonadotropin assayGonadotropin, chorionic (hcg); qualitativeN1$0.00
0002EG202785014HematocritBlood count; hematocrit (hct)N11$0.00
0002EH202785018HemoglobinBlood count; hemoglobin (hgb)N1$0.00
0002EJ202785025Complete cbc w/auto diff wbcBlood count; complete (cbc), automated (hgb, hct, rbc, wbc and platelet count) and automated differential wbc countN6$0.00
0002EK202785027Complete cbc automatedBlood count; complete (cbc), automated (hgb, hct, rbc, wbc and platelet count)N1$0.00
0002EL202785045Automated reticulocyte countBlood count; reticulocyte, automatedN4$0.00
0002EM202785049Automated platelet countBlood count; platelet, automatedN7$0.00
0002EN202785250Clot factor ix ptc/chrstmasClotting; factor ix (ptc or christmas)N1$0.00
0002EP202785270Clot factor xi ptaClotting; factor xi (pta)N1$0.00
0002EQ202785307Assay activated protein cActivated protein c (apc) resistance assayN16$0.00
0002ER202785347Coagulation time activatedCoagulation time; activatedN12$0.00
0002ES202785384Fibrinogen activityFibrinogen; activityN13$0.00
0002ET202785390Fibrinolysins screen i&rFibrinolysins or coagulopathy screen, interpretation and reportN12$0.00
0002EU202785460Hemoglobin fetalHemoglobin or rbcs, fetal, for fetomaternal hemorrhage; differential lysis (kleihauer-betke)N1$0.00
0002EV202785525Heparin neutralizationHeparin neutralizationN1$0.00
0002EW202785576Blood platelet aggregationPlatelet, aggregation (in vitro), each agentN111$0.00
0002EX202785610Prothrombin timeProthrombin time;N9$0.00
0002EY202785611Prothrombin testProthrombin time; substitution, plasma fractions, eachN4$0.00
0002EZ202785652Rbc sed rate automatedSedimentation rate, erythrocyte; automatedN5$0.00
0002FA202785660Rbc sickle cell testSickling of rbc, reductionN1$0.00
0002FB202785670Thrombin time plasmaThrombin time; plasmaN3$0.00
0002FC202785730Thromboplastin time partialThromboplastin time, partial (ptt); plasma or whole bloodN7$0.00
0002FD202785732Thromboplastin time partialThromboplastin time, partial (ptt); substitution, plasma fractions, eachN2$0.00
0002FE202786022Platelet antibodiesAntibody identification; platelet antibodiesN12$0.00
0002FF202786038Antinuclear antibodiesAntinuclear antibodies (ana);N1$0.00
0002FG202786039Antinuclear antibodies (ana)Antinuclear antibodies (ana); titerN1$0.00
0002FH202786160Complement antigenComplement; antigen, each componentN1$0.00
0002FJ202786225Dna antibody nativeDeoxyribonucleic acid (dna) antibody; native or double strandedN1$0.00
0002FK202786235Nuclear antigen antibodyExtractable nuclear antigen, antibody to, any method (eg, nrnp, ss-a, ss-b, sm, rnp, sc170, j01), each antibodyN1$0.00
0002FL202786317Immunoassay infectious agentImmunoassay for infectious agent antibody, quantitative, not otherwise specifiedN2$0.00
0002FM202786355B cells total countB cells, total countN1$0.00
0002FN202786359T cells total countT cells; total countN2$0.00
0002FP202786360T cell absolute count/ratioT cells; absolute cd4 and cd8 count, including ratioN1$0.00
0002FQ202786376Microsomal antibody eachMicrosomal antibodies (eg, thyroid or liver-kidney), eachN1$0.00
0002FR202786403Particle agglut antbdy scrnParticle agglutination; screen, each antibodyN12$0.00
0002FS202786406Particle agglut antbdy titrParticle agglutination; titer, each antibodyN3$0.00
0002FT202786635Coccidioides antibodyAntibody; coccidioidesN1$0.00
0002FU202786641Cryptococcus antibodyAntibody; cryptococcusN20$0.00
0002FV202786694Herpes simplex nes antbdyAntibody; herpes simplex, non-specific type testN20$0.00
0002FW202786704Hep b core antibody totalHepatitis b core antibody (hbcab); totalN1$0.00
0002FX202786787Varicella-zoster antibodyAntibody; varicella-zosterN7$0.00
0002FY202786832Hla class i high defin qualAntibody to human leukocyte antigens (hla), solid phase assays (eg, microspheres or beads, elisa, flow cytometry); high definition qualitative panel for identification of antibody specificities (eg, individual antigen per bead methodology), hla class iN16$0.00
0002FZ202786833Hla class ii high defin qualAntibody to human leukocyte antigens (hla), solid phase assays (eg, microspheres or beads, elisa, flow cytometry); high definition qualitative panel for identification of antibody specificities (eg, individual antigen per bead methodology), hla class iiN16$0.00
0002GA202787015Specimen infect agnt concntjConcentration (any type), for infectious agentsN11$0.00
0002GB202787070Culture othr specimn aerobicCulture, bacterial; any other source except urine, blood or stool, aerobic, with isolation and presumptive identification of isolatesN8$0.00
0002GC202787071Culture aerobic quant otherCulture, bacterial; quantitative, aerobic with isolation and presumptive identification of isolates, any source except urine, blood or stoolN4$0.00
0002GD202787075Cultr bacteria except bloodCulture, bacterial; any source, except blood, anaerobic with isolation and presumptive identification of isolatesN9$0.00
0002GE202787077Culture aerobic identifyCulture, bacterial; aerobic isolate, additional methods required for definitive identification, each isolateN4$0.00
0002GF202787081Culture screen onlyCulture, presumptive, pathogenic organisms, screening only;N1$0.00
0002GG202787086Urine culture/colony countCulture, bacterial; quantitative colony count, urineN1$0.00
0002GH202787101Skin fungi cultureCulture, fungi (mold or yeast) isolation, with presumptive identification of isolates; skin, hair, or nailN3$0.00
0002GJ202787103Blood fungus cultureCulture, fungi (mold or yeast) isolation, with presumptive identification of isolates; bloodN1$0.00
0002GK202787107Fungi identification moldCulture, fungi, definitive identification, each organism; moldN1$0.00
0002GL202787110Chlamydia cultureCulture, chlamydia, any sourceN1$0.00
0002GM202787116Mycobacteria cultureCulture, tubercle or other acid-fast bacilli (eg, tb, afb, mycobacteria) any source, with isolation and presumptive identification of isolatesN1$0.00
0002GN202787140Culture type immunofluorescCulture, typing; immunofluorescent method, each antiserumN2$0.00
0002GP202787143Culture typing glc/hplcCulture, typing; gas liquid chromatography (glc) or high pressure liquid chromatography (hplc) methodN1$0.00
0002GQ202787147Culture type immunologicCulture, typing; immunologic method, other than immunofluorescence (eg, agglutination grouping), per antiserumN4$0.00
0002GR202787149Dna/rna direct probeCulture, typing; identification by nucleic acid (dna or rna) probe, direct probe technique, per culture or isolate, each organism probedN3$0.00
0002GS202787153Dna/rna sequencingCulture, typing; identification by nucleic acid sequencing method, each isolate (eg, sequencing of the 16s rrna gene)N5$0.00
0002GT202787158Culture typing added methodCulture, typing; other methodsN20$0.00
0002GU202787169Macroscopic exam parasiteMacroscopic examination; parasiteN4$0.00
0002GV202787176Tissue homogenization cultrHomogenization, tissue, for cultureN12$0.00
0002GW202787177Ova and parasites smearsOva and parasites, direct smears, concentration and identificationN5$0.00
0002GX202787181Microbe susceptible diffuseSusceptibility studies, antimicrobial agent; agar dilution method, per agent (eg, antibiotic gradient strip)N1$0.00
0002GY202787184Microbe susceptible diskSusceptibility studies, antimicrobial agent; disk method, per plate (12 or fewer agents)N1$0.00
0002GZ202787186Microbe susceptible micSusceptibility studies, antimicrobial agent; microdilution or agar dilution (minimum inhibitory concentration [mic] or breakpoint), each multi-antimicrobial, per plateN3$0.00
0002HA202787205Smear gram stainSmear, primary source with interpretation; gram or giemsa stain for bacteria, fungi, or cell typesN28$0.00
0002HB202787206Smear fluorescent/acid staiSmear, primary source with interpretation; fluorescent and/or acid fast stain for bacteria, fungi, parasites, viruses or cell typesN2$0.00
0002HC202787207Smear special stainSmear, primary source with interpretation; special stain for inclusion bodies or parasites (eg, malaria, coccidia, microsporidia, trypanosomes, herpes viruses)N7$0.00
0002HD202787209Smear complex stainSmear, primary source with interpretation; complex special stain (eg, trichrome, iron hemotoxylin) for ova and parasitesN4$0.00
0002HE202787210Smear wet mount saline/inkSmear, primary source with interpretation; wet mount for infectious agents (eg, saline, india ink, koh preps)N4$0.00
0002HF202787250Virus inoculate eggs/animalVirus isolation; inoculation of embryonated eggs, or small animal, includes observation and dissectionN1$0.00
0002HG202787252Virus inoculation tissueVirus isolation; tissue culture inoculation, observation, and presumptive identification by cytopathic effectN1$0.00
0002HH202787253Virus inoculate tissue addlVirus isolation; tissue culture, additional studies or definitive identification (eg, hemabsorption, neutralization, immunofluorescence stain), each isolateN1$0.00
0002HJ202787254Virus inoculation shell viaVirus isolation; centrifuge enhanced (shell vial) technique, includes identification with immunofluorescence stain, each virusN1$0.00
0002HK202787255Genet virus isolate hsvVirus isolation; including identification by non-immunologic method, other than by cytopathic effect (eg, virus specific enzymatic activity)N3$0.00
0002HL202787327Cryptococcus neoform ag iaInfectious agent antigen detection by immunoassay technique (eg, enzyme immunoassay [eia], enzyme-linked immunosorbent assay [elisa], fluorescence immunoassay [fia], immunochemiluminometric assay [imca]), qualitative or semiquantitative; cryptococcus neoformansN13$0.00
0002HM202787328Cryptosporidium ag iaInfectious agent antigen detection by immunoassay technique (eg, enzyme immunoassay [eia], enzyme-linked immunosorbent assay [elisa], fluorescence immunoassay [fia], immunochemiluminometric assay [imca]), qualitative or semiquantitative; cryptosporidiumN11$0.00
0002HN202787329Giardia ag iaInfectious agent antigen detection by immunoassay technique (eg, enzyme immunoassay [eia], enzyme-linked immunosorbent assay [elisa], fluorescence immunoassay [fia], immunochemiluminometric assay [imca]), qualitative or semiquantitative; giardiaN13$0.00
0002HP202787338Hpylori stool ag iaInfectious agent antigen detection by immunoassay technique (eg, enzyme immunoassay [eia], enzyme-linked immunosorbent assay [elisa], fluorescence immunoassay [fia], immunochemiluminometric assay [imca]), qualitative or semiquantitative; helicobacter pylori, stoolN148$0.00
0002HQ202787389Hiv-1 ag w/hiv-1&-2 ab ag iaInfectious agent antigen detection by immunoassay technique (eg, enzyme immunoassay [eia], enzyme-linked immunosorbent assay [elisa], fluorescence immunoassay [fia], immunochemiluminometric assay [imca]), qualitative or semiquantitative; hiv-1 antigen(s), with hiv-1 and hiv-2 antibodies, single resultN4$0.00
0002HR202787483Cns dna amp probe type 12-25Infectious agent detection by nucleic acid (dna or rna); central nervous system pathogen (eg, neisseria meningitidis, streptococcus pneumoniae, listeria, haemophilus influenzae, e. coli, streptococcus agalactiae, enterovirus, human parechovirus, herpes simplex virus type 1 and 2, human herpesvirus 6, cytomegalovirus, varicella zoster virus, cryptococcus), includes multiplex reverse transcription, when performed, and multiplex amplified probe technique, multiple types or subtypes, 12-25 targetsN15$0.00
0002HS202787486Chlmyd pneum dna amp probeInfectious agent detection by nucleic acid (dna or rna); chlamydia pneumoniae, amplified probe techniqueN1$0.00
0002HT202787491Chlmyd trach dna amp probeInfectious agent detection by nucleic acid (dna or rna); chlamydia trachomatis, amplified probe techniqueN11$0.00
0002HU202787496Cytomeg dna amp probeInfectious agent detection by nucleic acid (dna or rna); cytomegalovirus, amplified probe techniqueN5$0.00
0002HV202787497Cytomeg dna quantInfectious agent detection by nucleic acid (dna or rna); cytomegalovirus, quantificationN4$0.00
0002HW202787498Enterovirus probe&revrs trnsInfectious agent detection by nucleic acid (dna or rna); enterovirus, amplified probe technique, includes reverse transcription when performedN36$0.00
0002HX202787502Influenza dna amp probeInfectious agent detection by nucleic acid (dna or rna); influenza virus, for multiple types or sub-types, includes multiplex reverse transcription, when performed, and multiplex amplified probe technique, first 2 types or sub-typesN7$0.00
0002HY202787503Influenza dna amp prob addlInfectious agent detection by nucleic acid (dna or rna); influenza virus, for multiple types or sub-types, includes multiplex reverse transcription, when performed, and multiplex amplified probe technique, each additional influenza virus type or sub-type beyond 2 (list separately in addition to code for primary procedure)N8$0.00

This is the start of the file's text. The full file is on GovTribe.

File details come from the government source that posted it. Updated .